Lundström Erik, Zini Andrea, Wahlgren Nils, Ahmed Niaz
Department of Neurology, Karolinska University Hospital & Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Stroke Unit, Department of Neuroscience, Nuovo Ospedale Civile "S Agostino-Estense," AUSL Modena, Modena, Italy.
BMJ Open. 2015 Nov 25;5(11):e009109. doi: 10.1136/bmjopen-2015-009109.
To describe the frequency and outcome of isolated dysphasia among patients treated with intravenous thrombolysis (IVT).
Patients registered in the SITS International Stroke Thrombolysis Register (SITS-ISTR).
Patients with stroke (N=58,293) treated with IVT between December 2002 and December 2012.
A multinational, prospective, observational monitoring register.
Isolated dysphasia and modified Rankin Scale (mRS).
We identified patients presenting with isolated dysphasia by reviewing items within the baseline National Institutes of Health Stroke Scale (NIHSS). We performed descriptive statistics for baseline and demographic data, and reported patients' characteristics, radiological data and changes in their NIHSS score within 7 days and mRS score at 3 months. We also reported corresponding data from the general SITS-ISTR cohort.
We found isolated dysphasia at baseline in 1.14% (663/58,293) of all patients treated with IVT patients. Patients with isolated dysphasia had a longer onset to treatment time, lower proportion of visible infarctions on admission imaging scan and atrial fibrillation, and were less often classified as having large vessels causing strokes, in comparison with the rest of the SITS-ISTR. Symptomatic intracerebral haemorrhage occurred in 2.3% of patients per SITS-MOST definition and fatal outcome in 5.5%. At 7 days, 50% of patients with isolated dysphasia recovered completely and at 3 months, 86.3% patients were functionally independent (mRS score 0-2), 71.7% had an excellent outcome (mRS score 0-1) and 45.5% had an mRS score of 0.
A low proportion of patients with isolated dysphasia are treated with IVT. Half of these patients were fully recovered at 7 days.
描述接受静脉溶栓治疗(IVT)的患者中孤立性失语的发生率及预后。
纳入国际卒中溶栓登记研究(SITS-ISTR)的患者。
2002年12月至2012年12月期间接受IVT治疗的卒中患者(N = 58293)。
一个跨国、前瞻性、观察性监测登记研究。
孤立性失语和改良Rankin量表(mRS)。
通过回顾基线美国国立卫生研究院卒中量表(NIHSS)中的项目,确定表现为孤立性失语的患者。我们对基线和人口统计学数据进行描述性统计,并报告患者的特征、影像学数据以及他们在7天内NIHSS评分的变化和3个月时的mRS评分。我们还报告了SITS-ISTR总体队列的相应数据。
在所有接受IVT治疗的患者中(N = 58293),1.14%(663/58293)的患者在基线时存在孤立性失语。与SITS-ISTR的其他患者相比,孤立性失语患者从发病到治疗的时间更长,入院影像学扫描显示梗死灶的比例更低,心房颤动的比例更低,且较少被归类为由大血管导致的卒中。根据SITS-MOST定义,2.3%的患者发生有症状性脑出血,5.5%的患者出现致命结局。在7天时,50%的孤立性失语患者完全康复,在3个月时,86.3%的患者功能独立(mRS评分0 - 2);71.7%的患者预后良好(mRS评分0 - 1),45.5%的患者mRS评分为0。
接受IVT治疗的孤立性失语患者比例较低。这些患者中有一半在7天时完全康复。